This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Reducing Readmissions for COPD Through Collaborative Evidence-Based Care

Reducing Readmissions for COPD Through Collaborative Evidence-Based Care

Format

Webcast

Time to Complete

1 hour

Released

August 7, 2017

Expires

August 7, 2018
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CNE Contact Hour (includes 0.50 pharmacotherapy credits)
1.00 / CE for Pharmacists (0.10 CEUs)

Accredited Provider

Jointly provided by Global Education Group and Integrity Continuing Education

Commercial Supporter

Supported by an educational grant from Boehringer Ingelheim, Mylan, and Sunovion Pharmaceuticals, Inc.

Program Description

An estimated 15.7 million adults have been told by a physician or other health professional that they have chronic obstructive pulmonary disease (COPD). Adults with COPD are more likely to be unable to work and have diminished activities of daily living. They also have increased comorbid conditions, difficulty walking or climbing stairs, or need special equipment to manage health problems compared with adults without COPD. COPD is the 3rd most common cause of death in the US, just behind cancer and heart disease. Despite significant local and national efforts to reduce the burden of COPD, recent data from the Nationwide Inpatient Sample and Nationwide Emergency Department Sample has revealed that total hospitalizations and emergency department visits for COPD over the past decade have continued to increase. However, COPD is listed as one of the conditions in which hospitalizations are preventable to some degree.

Hospital Medicine Summit (HMS) is an innovative, multi-topic educational initiative designed specifically for hospital-based healthcare providers (hospitalists, internal medicine physicians, physician assistants, nurse practitioners, pharmacists, and nurses). With significant changes occurring in the healthcare system, there is an increased demand on hospital-based healthcare providers to provide care that impacts patients not only in the acute setting, but as they transition back into the community and are managed in the chronic-care healthcare system.

Intended Audience

This educational initiative has been designed for hospital-based healthcare providers, including physicians, physician assistants, nurse practitioners, registered nurses, and pharmacists.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe long-term management strategies that may reduce COPD-related hospital readmissions
  • Review important comorbidities of COPD as part of a management strategy to reduce readmissions
  • Incorporate cognitive and physical assessments during inpatient stays and outpatient visits to determine the appropriate device for patients with COPD
  • Improve communication between inpatient and outpatient healthcare providers who manage patients with COPD to better coordinate care transitions

Conflict Of Interest Disclosure Policy

Integrity Continuing Education, Inc. and Global Education Group require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education and Global Education Group for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Integrity Continuing Education and Global Education Group are committed to providing learners with high-quality CME/CE activities and related materials that promote improvement or quality in healthcare and not a specific proprietary business interest or a commercial interest.

The following faculty/planners reported their financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity under the Faculty heading below.

Faculty

B. Justin Krawitt, MD
Assistant Professor of Medicine
Geisel School of Medicine
Dartmouth College
Hanover, New Hampshire
Medical Director of Care Management, Patient Placement, and Clinical Documentation
Dartmouth-Hitchcock Medical Center
Lebanon, NH

Dr. Krawitt discloses the following:
Consultant: Sunovion Pharmaceuticals, Inc.

Planners and Managers Disclosures

The following planners and managers, Andrea Funk, Liddy Knight, Lindsay Borvansky, Ashley Marostica, RN, MSN, and Patima Tanapat, PhD, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians.

Designation Statement

Integrity Continuing Education designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

This educational activity for 1.00 contact hour is provided by Global Education Group.

Activity Type: Knowledge

Designated for 0.50 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

Credit

1.00

Type

CE for Pharmacists

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

Global Education Group designates this continuing education activity for 1.00 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number: 0530-9999-17-145-H01-P)

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integrity Continuing Education, Global Education Group, Boehringer Ingelheim, Mylan, and Sunovion Pharmaceuticals, Inc., do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Global Education Group, Boehringer Ingelheim, Mylan, and Sunovion Pharmaceuticals, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.

Instructions

There are no fees for participating and receiving CME credit for this activity. During the period of August 7, 2017 through August 7, 2018, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pre-test
  • Study the educational activity
  • Complete the post-test and the evaluation form
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better.

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or hms@integrityce.com.

For information about ACPE or ANCC accreditation of this activity, please contact Global at (303) 395-1782 or cme@globaleducationgroup.com.

If you have any questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue